Stoke Therapeutics

Type: Corporate
Industry: Life Sciences

Stoke Therapeutics is a biotech company using RNA science to deliver a new generation of genetic medicines. By using a proprietary platform that restores protein levels, we take aim at severe genetic diseases that have inadequate or no treatment options. Our first area of focus is Dravet syndrome, a severe and progressive form of epilepsy that strikes children within the first year or two of life. For more information, visit and follow Stoke on Twitter (@StokeTx).